Raghavendra Pillappa
Overview
Explore the profile of Raghavendra Pillappa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Madan E, Palma A, Vudatha V, Kumar A, Bhoopathi P, Wilhelm J, et al.
Nat Biotechnol
. 2024 Dec;
PMID: 39653752
Cell competition and fitness comparison between cancer and tumor microenvironment (TME) cells determine oncogenic fate. Our previous study established a role for human Flower isoforms as fitness fingerprints, where the...
2.
May L, Hu B, Jerajani P, Jagdeesh A, Alhawiti O, Cai L, et al.
Cancer Res
. 2024 Sep;
84(24):4140-4155.
PMID: 39312191
There is a significant sex bias in lung cancer, with males showing increased mortality compared with females. A better mechanistic understanding of these differences could help identify therapeutic targets to...
3.
Lin S, Tran C, Bandari E, Romagnoli T, Li Y, Chu M, et al.
Int J Surg Pathol
. 2024 Apr;
32(8):1449-1458.
PMID: 38627896
The identification of mitotic figures is essential for the diagnosis, grading, and classification of various different tumors. Despite its importance, there is a paucity of literature reporting the consistency in...
4.
Martin D, Smith S, Chesney A, Jackson-Cook C, Pillappa R
Am J Clin Pathol
. 2022 Apr;
158(2):283-290.
PMID: 35482487
Objectives: To compare the performance of the rabbit monoclonal antihuman CD246 antibody (D5F3 clone) with the established ALK1 clone for immunohistochemical assessment of anaplastic large cell lymphoma (ALCL). Methods: Archival...
5.
Kim M, Vu N, Wang X, Bulut G, Wang M, Uram-Tuculescu C, et al.
Mol Cancer Res
. 2022 Apr;
20(8):1284-1294.
PMID: 35412615
Implications: Our findings show that C9b can directly activate NF-κB pathway in vivo to modulate lung inflammation, immune cell influx, and peripheral immune responses, which demonstrates that C9b is key...
6.
Pillappa R, Wiles A, Sayeed S, Robila V
Am J Clin Pathol
. 2022 Mar;
158(2):187-198.
PMID: 35285890
Objectives: To examine the potential of cyclin D1/podoplanin dual immunohistochemical stain to differentiate malignant mesothelioma from reactive mesothelial proliferations. Methods: Cyclin D1/podoplanin dual immunohistochemistry was performed on 34 surgical cases...
7.
Gillam J, Pillappa R, Idowu M, Boardman C, Sullivan S, Sayeed S
SAGE Open Med Case Rep
. 2022 Mar;
10:2050313X221081361.
PMID: 35273799
This case report describes a unique pattern of human epidermal growth factor receptor 2 expression in a patient with uterine carcinosarcoma. The endometrial tumor showed biphasic morphology composed of serous...
8.
Fadl S, Pillappa R, Parker M
Radiol Cardiothorac Imaging
. 2021 Nov;
3(5):e210219.
PMID: 34778789
No abstract available.
9.
Yekelchyk M, Madan E, Wilhelm J, Short K, Palma A, Liao L, et al.
EMBO Mol Med
. 2021 Oct;
13(11):e13714.
PMID: 34661368
Risk stratification of COVID-19 patients is essential for pandemic management. Changes in the cell fitness marker, hFwe-Lose, can precede the host immune response to infection, potentially making such a biomarker...
10.
Allen A, Smith S, Pillappa R, Boikos S, Medalion B, Grizzard J, et al.
Respir Med Case Rep
. 2021 Aug;
33:101414.
PMID: 34401262
Intimal sarcoma (IS) is a rare malignancy arising in the great vessels or heart, most commonly in the pulmonary artery, primarily treated with surgical intervention. We report a case of...